CLINICAL_TRIALS
trial_result
· 2020-02-13
Clinical Trial Update: Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris [Phase 4]
Summary
Phase 4 safety and efficacy trial of ACZONE (dapsone) gel 7.5% in children 9-11 with acne vulgaris has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Almirall, S.A. | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2020-02-13